Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · IEX Real-Time Price · USD
10.78
+0.49 (4.76%)
Jul 26, 2024, 4:00 PM EDT - Market closed
Centessa Pharmaceuticals Market Cap
Centessa Pharmaceuticals has a market cap or net worth of $1.08 billion as of July 26, 2024. Its market cap has increased by 38.13% in one year.
Market Cap
1.08B
Enterprise Value
938.56M
1-Year Change
38.13%
Ranking
Category
Stock Price
$10.78
Market Cap Chart
Since the IPO on May 28, 2021, Centessa Pharmaceuticals's market cap has decreased from $1.75B to $1.08B, a decrease of -38.05%. That is a compound annual growth rate of -14.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 1.16B | 49.68% |
| Dec 29, 2023 | 777.10M | 165.04% |
| Dec 30, 2022 | 293.20M | -71.04% |
| Dec 31, 2021 | 1.01B | -42.10% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Calliditas Therapeutics AB (publ) | 1.03B |
| Viridian Therapeutics | 1.01B |
| AnaptysBio | 1.01B |
| ARS Pharmaceuticals | 1.01B |
| Bicycle Therapeutics | 1.00B |
| OPKO Health | 989.73M |
| Silence Therapeutics | 982.29M |
| Praxis Precision Medicines | 977.03M |